Search results
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 4 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 3 days agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 6 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Emcure Pharma On The Way To D-Street Debut; IPO On July 3
Free Press Journal· 5 days agoThe Initial Public Offer of 'Emcure Pharmaceutical's will begin accepting subscriptions on July 3. A...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 3 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
From being labeled as 'selfish' for taking out time for herself to sharing her love for Gujarati...
The Times of India· 6 days agoFrom being labeled as selfish for prioritizing self-care to sharing her passion for Gujarati...
Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details
The Economic Times· 1 day agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked over 13 times so far on the...
IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week
CNBC Awaaz· 6 days agoIn the coming week, the IPOs of Emcure Pharmaceuticals, in which shark tank fame Namita Thapar is...
Indian pharma companies hope to get incentives for innovation: Union Budget 2024
Hindustan Times· 57 minutes agoWhy is India's pharmaceuticals industry important? India is the third largest manufacturer of...
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 1 day agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important...